These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2895400)

  • 1. Screening for ovarian cancer by CA-125 measurement.
    Jacobs I
    Lancet; 1988 Apr; 1(8590):889. PubMed ID: 2895400
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for ovarian cancer by CA-125 measurement.
    Cruickshank DJ
    Lancet; 1988 Mar; 1(8584):540-1. PubMed ID: 2893964
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ; Oram DH; Bast RC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer.
    Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1990 Sep; 36(3):221-8. PubMed ID: 2199246
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma.
    Mann WJ; Patsner B; Cohen H; Loesch M
    J Natl Cancer Inst; 1988 Apr; 80(3):208-9. PubMed ID: 3162284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
    Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
    BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodiagnosis of ovarian tumors.
    Jacobs I; Bast RC
    Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of serum CA 125 in ovarian cancers.
    Yuan CC; Ng HT; Yeh SH; Jeng FS; Chen SL; Tsai LC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):153-60. PubMed ID: 3484240
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
    Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
    Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
    Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
    Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
    Bast R; Woolas R
    BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovarian cancer screening: new trial tries new twists.
    McNeil C
    J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479
    [No Abstract]   [Full Text] [Related]  

  • 16. [CA 125--a new characteristic in the diagnosis of ovarian carcinoma].
    Tosner J
    Cesk Gynekol; 1987 Jun; 52(5):381-5. PubMed ID: 3477330
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of CA 125 serum assay in the management of ovarian cancer. Commentary.
    Jacobs I; Oram D
    Br J Obstet Gynaecol; 1987 Aug; 94(8):819-21. PubMed ID: 3478081
    [No Abstract]   [Full Text] [Related]  

  • 18. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of CA.125 as a co-adjuvant test in the diagnosis and follow-up of ovarian cancer].
    Hernández Briz MJ; Díaz Redondo A; Mújica Menéndez I; Merino Ramírez J; Crespo Azanza E; Fernández Villoria E; Sánchez Martín JA
    Rev Clin Esp; 1986 Oct; 179(5):240-2. PubMed ID: 3466260
    [No Abstract]   [Full Text] [Related]  

  • 20. CA 15-3 serum levels in ovarian cancer.
    Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
    Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.